High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome

Arnaud Jaccard(Centre Hospitalier Universitaire de Limoges), Jean‐Paul Fermand(Sorbonne Université), Bruno Royer(Centre Hospitalier Universitaire Amiens-Picardie), Dominique Bordessoule(Centre Hospitalier Universitaire de Limoges), Jean‐Claude Brouet(Centre National de la Recherche Scientifique)
Blood
April 15, 2002
10.1182/blood.v99.8.3057
Cited by 137

Related Papers

Biologic and clinical significance of cryoglobulins
|The American Journal of Medicine|1974|1.7k
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia
|Blood|1999|745
High-Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: Up-front or Rescue Treatment? Results of a Multicenter Sequential Randomized Clinical Trial
|Blood|1998|539